Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEARCA:DVP NYSEARCA:LST NASDAQ:NITE NASDAQ:VMOT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDVPRoundhill Acquirers Deep Value ETF$19,431.04$16.14▼$33.54$23.18MN/A97,855 shs20,680 shsLSTLeuthold Select Industries ETF$36.86-0.5%$35.84$29.04▼$37.14$27.90MN/A4,950 shs286 shsNITENightstar Therapeutics$31.91-0.9%$25.41$9.59▼$29.55$1.07B2.84185,808 shs424 shsVMOTAlpha Architect Value Momentum Trend ETF$26.78+0.4%$26.49$23.03▼$27.77$22.22M0.481,645 shs1,888 shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDVPRoundhill Acquirers Deep Value ETF0.00%0.00%0.00%0.00%0.00%LSTLeuthold Select Industries ETF-0.54%+0.33%+2.13%+14.54%+3,685,999,900.00%NITENightstar Therapeutics+0.33%+1.38%+6.43%+23.66%+30.80%VMOTAlpha Architect Value Momentum Trend ETF0.00%+0.71%+1.82%+11.82%+7.62%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDVPRoundhill Acquirers Deep Value ETFN/AN/AN/AN/AN/AN/AN/AN/ALSTLeuthold Select Industries ETFN/AN/AN/AN/AN/AN/AN/AN/ANITENightstar TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/AVMOTAlpha Architect Value Momentum Trend ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDVPRoundhill Acquirers Deep Value ETF 0.00N/AN/AN/ALSTLeuthold Select Industries ETF 2.75Moderate Buy$36.86N/ANITENightstar Therapeutics 0.00N/AN/AN/AVMOTAlpha Architect Value Momentum Trend ETF 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDVPRoundhill Acquirers Deep Value ETFN/AN/AN/AN/AN/AN/ALSTLeuthold Select Industries ETFN/AN/AN/AN/AN/AN/ANITENightstar TherapeuticsN/AN/AN/AN/A$5.89 per shareN/AVMOTAlpha Architect Value Momentum Trend ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDVPRoundhill Acquirers Deep Value ETFN/AN/A0.00N/AN/AN/AN/AN/AN/ALSTLeuthold Select Industries ETFN/AN/A17.27∞N/AN/AN/AN/AN/ANITENightstar Therapeutics-$36.86M-$1.26N/AN/AN/AN/A-30.89%-27.65%N/AVMOTAlpha Architect Value Momentum Trend ETFN/AN/A13.56∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDVPRoundhill Acquirers Deep Value ETF$1.737.86%N/AN/AN/ALSTLeuthold Select Industries ETFN/AN/AN/AN/AN/ANITENightstar TherapeuticsN/AN/AN/AN/AN/AVMOTAlpha Architect Value Momentum Trend ETF$0.642.39%N/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDVPRoundhill Acquirers Deep Value ETFN/AN/AN/ALSTLeuthold Select Industries ETFN/AN/AN/ANITENightstar TherapeuticsN/A8.548.54VMOTAlpha Architect Value Momentum Trend ETFN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDVPRoundhill Acquirers Deep Value ETFN/ALSTLeuthold Select Industries ETFN/ANITENightstar Therapeutics32.83%VMOTAlpha Architect Value Momentum Trend ETFN/AInsider OwnershipCompanyInsider OwnershipDVPRoundhill Acquirers Deep Value ETFN/ALSTLeuthold Select Industries ETFN/ANITENightstar TherapeuticsN/AVMOTAlpha Architect Value Momentum Trend ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDVPRoundhill Acquirers Deep Value ETFN/A1.00 millionN/ANot OptionableLSTLeuthold Select Industries ETFN/A757,000N/AN/ANITENightstar Therapeutics4733.54 millionN/ANot OptionableVMOTAlpha Architect Value Momentum Trend ETFN/A830,000N/AN/ADVP, VMOT, NITE, and LST HeadlinesRecent News About These CompaniesTime for Global Equities ETFs?September 20, 2024 | zacks.comTop HeadlinesView All HeadlinesDo They Know Something? Insiders & Congress Buy UnitedHealthBy Brian O'Connell | July 9, 2025View Do They Know Something? Insiders & Congress Buy UnitedHealthTop Steel Picks for the Coming Infrastructure BoomBy Chris Markoch | June 25, 2025View Top Steel Picks for the Coming Infrastructure BoomInsiders Spent Millions on These 3 Stocks Over the Past 2 MonthsBy Leo Miller | July 17, 2025View Insiders Spent Millions on These 3 Stocks Over the Past 2 MonthsUPS Is Outpacing the Market: A Green Light for Investors?By Jeffrey Neal Johnson | June 27, 2025View UPS Is Outpacing the Market: A Green Light for Investors?Healthcare Stocks Hit Valuation Bottom, 3 Names to ReboundBy Gabriel Osorio-Mazilli | July 23, 2025View Healthcare Stocks Hit Valuation Bottom, 3 Names to ReboundDVP, VMOT, NITE, and LST Company DescriptionsRoundhill Acquirers Deep Value ETF NYSEARCA:DVPLeuthold Select Industries ETF NYSEARCA:LST$36.86 -0.20 (-0.54%) As of 07/24/2025 04:10 PM EasternThe Leuthold Select Industries ETF (LST) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, seeking capital appreciation by broadly investing in US equity securities. The selection process utilizes a quantitative approach that focuses on shifts in industry groups LST was launched on Jan 21, 2025 and is issued by Leuthold.Nightstar Therapeutics NASDAQ:NITENightstar Therapeutics plc, a clinical-stage gene therapy company, focuses on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases in the United Kingdom. The company's lead product candidate is NSR-REP1, a candidate that is in phase 3 clinical development for the treatment of patients with choroideremia. It is also developing NSR-RPGR, a candidate that is in Phase 1/2 clinical trials for the treatment of patients with X-linked retinitis pigmentosa, an inherited X-linked recessive retinal disease; and NSR-BEST1, a candidate that is in preclinical development stage for the treatment of best vitelliform macular dystrophy. In addition, the company is developing NSR-ABCA4, a candidate that is in preclinical development stage for the treatment of Stargardt disease. The company was founded in 2013 and is headquartered in London, the United Kingdom.Alpha Architect Value Momentum Trend ETF NASDAQ:VMOT$26.78 +0.10 (+0.36%) As of 07/21/2025The Alpha Architect Value Momentum Trend ETF (VMOT) is an exchange-traded fund that mostly invests in total market equity. The fund is an active, equal-risk-weighted portfolio of value- and momentum-oriented ETFs. The fund can fully hedge its equity exposure in down-trending markets. VMOT was launched on May 3, 2017 and is issued by Alpha Architect. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Krispy Kreme: A Meme Stock Sugar Rush or a Sustainable Treat? From Zero to Hero? Why GoPro's Rally Could Be More Than It Seems A Smokin’ Hot Entry Point for Chipotle Stock Opens in Q3 Alphabet’s Breakout Quarter Signals a New Leadership Phase Tesla Just Hit a Fork in the Road—Could the Bulls Lose Control? GE Vernova's Q2 Electrifies Stock, What's Next For This Top Name? Is Former Dividend Aristocrat AT&T a Buy After Q2 Earnings? What's Behind Opendoor Technologies' Rally? Is Meme Mania Back? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
